On May 12th, the biaseparations.com website will be retired and migrated tosartorius.com.Learn moreabout our combined offering today!
22Nov2022
Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production
25Oct2022
Downstream AAV Production: A Targeted Approach to improve Empty / Full capsid separation (a Case Study with Pharmaron)
22Jun2022
New Achievement: The best performing company in Slovenia
22Jun2022
Thank you for attending Monolith Summer Symposium!
1Apr2022
BIA Separations (Sartorius) is now part of new EIC Pathfinder project Yscript
3Nov2021
BioNet and Sartorius’ company BIA Separations collaborate on production process development of mRNA vaccines
29Jun2021
Introduction of speCIMen
22Mar2021
Sartorius Creates a Premium Gene Therapy and Vaccine Portfolio With the Acquisition of BIA Separations
22Mar2021
BIA Separations to supply columns for mRNA purification
28Jan2021
BIA Separations welcomes a new specialized expert to the team
21Dec2020
VivaZome and BIA Separations to collaborate on downstream technology for exosome purification
1Dec2020
BIA Separations receives highest national award for innovations